Phase 2A trial of Ad5.F35-GUCY2C-PADRE vaccine for recurrence prevention in gastrointestinal (GI) adenocarcinomas post definitive surgery and adjuvant therapies.

Autor: Bashir, Babar, Mitchell, Edith P., Posey, James, Basu Mallick, Atrayee, Lin, Daniel, Singla, Rajan, Fernandez, Eduardo, Ramirez, Michael J., Singh, Jagmohan, Kraft, Walter K., Crutcher, Madison, Lefler, Daniel S., Leiby, Benjamin E., Zhan, Tingting, Waldman, Scott A., Snook, Adam E.
Zdroj: Journal of Clinical Oncology; 2024 Supplement 3, Vol. 42, pTPS235-TPS235, 235p
Databáze: Supplemental Index